199 related articles for article (PubMed ID: 31861013)
1. Reactivation of latent tuberculosis infection induced by cabazitaxel in a patient with prostate cancer: A case report.
Hashimoto M; Minami T; Hamaguchi M; Fujimoto S; Takahashi T; Kikuchi T; Adomi S; Banno E; Ohzeki T; Shimizu N; Mori Y; Nozawa M; Nose K; Yoshimura K; Uemura H
Medicine (Baltimore); 2019 Dec; 98(51):e18436. PubMed ID: 31861013
[TBL] [Abstract][Full Text] [Related]
2. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
3. Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant.
Ishiwada N; Tokunaga O; Nagasawa K; Ichimoto K; Kinoshita K; Hishiki H; Kohno Y
Tohoku J Exp Med; 2013 Mar; 229(3):221-5. PubMed ID: 23470647
[TBL] [Abstract][Full Text] [Related]
4. Use of steroids to treat anti-tumor necrosis factor α induced tuberculosis-associated immune reconstitution inflammatory syndrome: Case report and literature review.
Nabeya D; Kinjo T; Yamaniha K; Yamazato S; Tome R; Miyagi K; Nakamura H; Kinjo T; Haranaga S; Higa F; Fujita J
Medicine (Baltimore); 2020 Oct; 99(43):e22076. PubMed ID: 33120729
[TBL] [Abstract][Full Text] [Related]
5. Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case report.
Kosaka T; Hongo H; Oya M
BMC Cancer; 2019 Jun; 19(1):562. PubMed ID: 31185946
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroid-induced exacerbation of cryptic miliary tuberculosis to acute respiratory distress syndrome: A case report.
Song M; Kim SJ; Yoo JY
Medicine (Baltimore); 2020 Nov; 99(46):e23204. PubMed ID: 33181702
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan.
Huang SF; Chen MH; Wang FD; Tsai CY; Fung CP; Su WJ
J Microbiol Immunol Infect; 2018 Dec; 51(6):784-793. PubMed ID: 28739436
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients.
Terada N; Kamoto T; Tsukino H; Mukai S; Akamatsu S; Inoue T; Ogawa O; Narita S; Habuchi T; Yamashita S; Mitsuzuka K; Arai Y; Kandori S; Kojima T; Nishiyama H; Kawamura Y; Shimizu Y; Terachi T; Sugi M; Kinoshita H; Matsuda T; Yamada Y; Yamamoto S; Hirama H; Sugimoto M; Kakehi Y; Sakurai T; Tsuchiya N
BMC Cancer; 2019 Feb; 19(1):156. PubMed ID: 30770773
[TBL] [Abstract][Full Text] [Related]
9. Management of Latent Tuberculosis Infection in Children from Developing Countries.
Jain A; Lodha R
Indian J Pediatr; 2019 Aug; 86(8):740-745. PubMed ID: 30741387
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States.
LoBue PA; Enarson DA; Thoen TC
Int J Tuberc Lung Dis; 2010 Oct; 14(10):1226-32. PubMed ID: 20843412
[TBL] [Abstract][Full Text] [Related]
11. Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme.
Heidenreich A; Scholz HJ; Rogenhofer S; Arsov C; Retz M; Müller SC; Albers P; Gschwend J; Wirth M; Steiner U; Miller K; Heinrich E; Trojan L; Volkmer B; Honecker F; Bokemeyer C; Keck B; Otremba B; Ecstein-Fraisse E; Pfister D
Eur Urol; 2013 Jun; 63(6):977-82. PubMed ID: 23116658
[TBL] [Abstract][Full Text] [Related]
12. Treatment guidelines for latent tuberculosis infection.
;
Kekkaku; 2014 Jan; 89(1):21-37. PubMed ID: 24654427
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.
Ramos GP; Stroh G; Al-Bawardy B; Faubion WA; Papadakis KA; Escalante P
Inflamm Bowel Dis; 2018 Sep; 24(10):2272-2277. PubMed ID: 29718223
[TBL] [Abstract][Full Text] [Related]
14. Miliary Tuberculosis during R-MPV Therapy in an Elderly Patient with Primary Central Nerve System Lymphoma: A Case Report.
Take Y; Shirahata M; Sakai J; Kubota Y; Suzuki T; Adachi JI; Maesaki S; Mishima K; Nishikawa R
Case Rep Oncol; 2023; 16(1):1054-1059. PubMed ID: 37900802
[TBL] [Abstract][Full Text] [Related]
15. Drug susceptibility pattern of Mycobacterium tuberculosis in adult patients with miliary tuberculosis.
Irfan M; Hussain SF; Jabeen K; Islam M
Trop Doct; 2007 Jul; 37(3):182-4. PubMed ID: 17716515
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Study to Monitor for Tuberculosis During Anti-tumour Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease and Immune-mediated Inflammatory Diseases.
Lee CK; Wong SHV; Lui G; Tang W; Tam LS; Ip M; Hung E; Chen M; Wu JC; Ng SC
J Crohns Colitis; 2018 Jul; 12(8):954-962. PubMed ID: 29757355
[TBL] [Abstract][Full Text] [Related]
17. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
18. Using the TBAg/PHA ratio in the T-SPOT(®).TB assay to distinguish TB disease from LTBI in an endemic area.
Wang F; Hou HY; Wu SJ; Zhu Q; Huang M; Yin B; Huang J; Pan YY; Mao L; Sun ZY
Int J Tuberc Lung Dis; 2016 Apr; 20(4):487-93. PubMed ID: 26970158
[TBL] [Abstract][Full Text] [Related]
19. Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.
Marks SM; Mase SR; Morris SB
Clin Infect Dis; 2017 Jun; 64(12):1670-1677. PubMed ID: 28329197
[TBL] [Abstract][Full Text] [Related]
20. [Lessons learned from tuberculosis outbreak cases].
Kato S; Kuwabara K
Kekkaku; 2014 Feb; 89(2):77-88. PubMed ID: 24716362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
